| Year |
Citation |
Score |
| 2019 |
Bhattacharyya S, Ahmed AT, Arnold M, Liu D, Luo C, Zhu H, Mahmoudiandehkordi S, Neavin D, Louie G, Dunlop BW, Frye MA, Wang L, Weinshilboum RM, Krishnan RR, Rush AJ, et al. Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients. Translational Psychiatry. 9: 173. PMID 31273200 DOI: 10.1038/S41398-019-0507-5 |
0.365 |
|
| 2018 |
Liu D, Ray B, Neavin DR, Zhang J, Athreya AP, Biernacka JM, Bobo WV, Hall-Flavin DK, Skime MK, Zhu H, Jenkins GD, Batzler A, Kalari KR, Boakye-Agyeman F, Matson WR, et al. Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics. Translational Psychiatry. 8: 10. PMID 29317604 DOI: 10.1038/S41398-017-0056-8 |
0.327 |
|
| 2017 |
Elbadawi-Sidhu M, Baillie RA, Zhu H, Chen YI, Goodarzi MO, Rotter JI, Krauss RM, Fiehn O, Kaddurah-Daouk R. Pharmacometabolomic signature links simvastatin therapy and insulin resistance. Metabolomics : Open Access. 13. PMID 29732238 DOI: 10.1007/S11306-016-1141-3 |
0.308 |
|
| 2017 |
Toledo JB, Arnold M, Kastenmüller G, Chang R, Baillie RA, Han X, Thambisetty M, Tenenbaum JD, Suhre K, Thompson JW, John-Williams LS, MahmoudianDehkordi S, Rotroff DM, Jack JR, Motsinger-Reif A, ... ... Zhu H, et al. Metabolic network failures in Alzheimer's disease-A biochemical road map. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28341160 DOI: 10.1016/J.Jalz.2017.01.020 |
0.301 |
|
| 2016 |
Gupta M, Neavin D, Liu D, Biernacka J, Hall-Flavin D, Bobo WV, Frye MA, Skime M, Jenkins GD, Batzler A, Kalari K, Matson W, Bhasin SS, Zhu H, Mushiroda T, et al. TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics. Molecular Psychiatry. PMID 26903268 DOI: 10.1038/Mp.2016.6 |
0.324 |
|
| 2015 |
Zhu HX, Xue ZQ, Qiu WY, Zeng ZJ, Dai JP, Ma C, Luo XG, Yan XX. Age-related intraneuronal accumulation of αII-spectrin breakdown product SBDP120 in the human cerebrum is enhanced in Alzheimer's disease. Experimental Gerontology. 69: 43-52. PMID 26051930 DOI: 10.1016/J.Exger.2015.06.003 |
0.307 |
|
| 2013 |
Krauss RM, Zhu H, Kaddurah-Daouk R. Pharmacometabolomics of statin response. Clinical Pharmacology and Therapeutics. 94: 562-5. PMID 23945822 DOI: 10.1038/Clpt.2013.164 |
0.375 |
|
| 2013 |
McEvoy J, Baillie RA, Zhu H, Buckley P, Keshavan MS, Nasrallah HA, Dougherty GG, Yao JK, Kaddurah-Daouk R. Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics. Plos One. 8: e68717. PMID 23894336 DOI: 10.1371/Journal.Pone.0068717 |
0.306 |
|
| 2013 |
Zhu H, Bogdanov MB, Boyle SH, Matson W, Sharma S, Matson S, Churchill E, Fiehn O, Rush JA, Krishnan RR, Pickering E, Delnomdedieu M, Kaddurah-Daouk R. Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway. Plos One. 8: e68283. PMID 23874572 DOI: 10.1371/Journal.Pone.0068283 |
0.364 |
|
| 2013 |
Yerges-Armstrong LM, Ellero-Simatos S, Georgiades A, Zhu H, Lewis JP, Horenstein RB, Beitelshees AL, Dane A, Reijmers T, Hankemeier T, Fiehn O, Shuldiner AR, Kaddurah-Daouk R. Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomics. Clinical Pharmacology and Therapeutics. 94: 525-32. PMID 23839601 DOI: 10.1038/Clpt.2013.119 |
0.354 |
|
| 2013 |
Kaddurah-Daouk R, Zhu H, Sharma S, Bogdanov M, Rozen SG, Matson W, Oki NO, Motsinger-Reif AA, Churchill E, Lei Z, Appleby D, Kling MA, Trojanowski JQ, Doraiswamy PM, Arnold SE, et al. Alterations in metabolic pathways and networks in Alzheimer's disease. Translational Psychiatry. 3: e244. PMID 23571809 DOI: 10.1038/Tp.2013.18 |
0.338 |
|
| 2013 |
Wikoff WR, Frye RF, Zhu H, Gong Y, Boyle S, Churchill E, Cooper-Dehoff RM, Beitelshees AL, Chapman AB, Fiehn O, Johnson JA, Kaddurah-Daouk R. Pharmacometabolomics reveals racial differences in response to atenolol treatment. Plos One. 8: e57639. PMID 23536766 DOI: 10.1371/Journal.Pone.0057639 |
0.331 |
|
| 2013 |
Kaddurah-Daouk R, Bogdanov MB, Wikoff WR, Zhu H, Boyle SH, Churchill E, Wang Z, Rush AJ, Krishnan RR, Pickering E, Delnomdedieu M, Fiehn O. Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo Translational Psychiatry. 3. PMID 23340506 DOI: 10.1038/Tp.2012.142 |
0.367 |
|
| 2013 |
Kaddurah-Daouk R, Baillie RA, Zhu H, Zeng ZB, Wiest MM, Nguyen UT, Wojnoonski K, Watkins SM, Trupp M, Krauss RM. Correction: Enteric microbiome metabolites correlate with response to simvastatin treatment (PLoS ONE) Plos One. 8. DOI: 10.1371/Annotation/8E8E95Ca-1Ac3-4Acf-Abcb-223Cd11Ac1C1 |
0.449 |
|
| 2012 |
Kaddurah-Daouk R, Yuan P, Boyle SH, Matson W, Wang Z, Zeng ZB, Zhu H, Dougherty GG, Yao JK, Chen G, Guitart X, Carlson PJ, Neumeister A, Zarate C, Krishnan RR, et al. Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile. Scientific Reports. 2: 667. PMID 22993692 DOI: 10.1038/Srep00667 |
0.454 |
|
| 2012 |
Zhu H, Li L, Zhou H. Nonlinear dimension reduction with Wright-Fisher kernel for genotype aggregation and association mapping. Bioinformatics (Oxford, England). 28: i375-i381. PMID 22962455 DOI: 10.1093/Bioinformatics/Bts406 |
0.303 |
|
| 2012 |
Trupp M, Zhu H, Wikoff WR, Baillie RA, Zeng ZB, Karp PD, Fiehn O, Krauss RM, Kaddurah-Daouk R. Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment. Plos One. 7: e38386. PMID 22808006 DOI: 10.1371/Journal.Pone.0038386 |
0.471 |
|
| 2012 |
Fang Y, Zhang L, Zeng Z, Lian Y, Jia Y, Zhu H, Xu Y. Promoter polymorphisms of SERPINE1 are associated with the antidepressant response to depression in Alzheimer's disease. Neuroscience Letters. 516: 217-20. PMID 22503724 DOI: 10.1016/j.neulet.2012.03.090 |
0.366 |
|
| 2012 |
Abo R, Hebbring S, Ji Y, Zhu H, Zeng ZB, Batzler A, Jenkins GD, Biernacka J, Snyder K, Drews M, Fiehn O, Fridley B, Schaid D, Kamatani N, Nakamura Y, et al. Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics. Pharmacogenetics and Genomics. 22: 247-53. PMID 22322242 DOI: 10.1097/Fpc.0B013E32835001C9 |
0.413 |
|
| 2011 |
Kaddurah-Daouk R, Boyle SH, Matson W, Sharma S, Matson S, Zhu H, Bogdanov MB, Churchill E, Krishnan RR, Rush AJ, Pickering E, Delnomdedieu M. Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. Translational Psychiatry. 1. PMID 22162828 DOI: 10.1038/Tp.2011.22 |
0.353 |
|
| 2011 |
Kaddurah-Daouk R, Baillie RA, Zhu H, Zeng ZB, Wiest MM, Nguyen UT, Wojnoonski K, Watkins SM, Trupp M, Krauss RM. Enteric microbiome metabolites correlate with response to simvastatin treatment. Plos One. 6: e25482. PMID 22022402 DOI: 10.1371/Journal.Pone.0025482 |
0.493 |
|
| 2011 |
Zhang L, Fang Y, Zeng Z, Lian Y, Wei J, Zhu H, Jia Y, Zhao X, Xu Y. BDNF gene polymorphisms are associated with Alzheimer's disease-related depression and antidepressant response. Journal of Alzheimer's Disease : Jad. 26: 523-30. PMID 21677379 DOI: 10.3233/JAD-2011-110113 |
0.359 |
|
| 2011 |
Ji Y, Hebbring S, Zhu H, Jenkins GD, Biernacka J, Snyder K, Drews M, Fiehn O, Zeng Z, Schaid D, Mrazek DA, Kaddurah-Daouk R, Weinshilboum RM. Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics. Clinical Pharmacology and Therapeutics. 89: 97-104. PMID 21107318 DOI: 10.1038/Clpt.2010.250 |
0.458 |
|
| 2010 |
Kaddurah-Daouk R, Baillie RA, Zhu H, Zeng ZB, Wiest MM, Nguyen UT, Watkins SM, Krauss RM. Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study. Metabolomics : Official Journal of the Metabolomic Society. 6: 191-201. PMID 20445760 DOI: 10.1007/S11306-010-0207-X |
0.464 |
|
| Show low-probability matches. |